Cannabis und Cannabinoide in der Palliativversorgung
| Autor: | Rupert Conrad, D. Emmert, Martin Mücke, Lukas Radbruch, T Rasche |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Background information
medicine.medical_specialty Palliative care biology business.industry Nausea Public Health Environmental and Occupational Health Human immunodeficiency virus (HIV) biology.organism_classification medicine.disease_cause 030210 environmental & occupational health 03 medical and health sciences Broad spectrum 0302 clinical medicine medicine In patient 030212 general & internal medicine Cannabis medicine.symptom Intensive care medicine business Cancer pain |
| Zdroj: | Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 62:830-835 |
| ISSN: | 1437-1588 1436-9990 |
| DOI: | 10.1007/s00103-019-02967-1 |
| Popis: | Cannabis and cannabinoids are discussed as a potential treatment for a broad spectrum of diseases and symptoms. This article presents current evidence for the use of cannabis and cannabinoids in palliative care and delivers background information. For this purpose recent literature was examined and evaluated. The authors focused on a systematic review and meta-analysis of cannabinoids in palliative care by Mucke et al.Overall, there is no high-quality evidence for the use of cannabis and cannabinoids in palliative care. Cannabinoids may be considered as a therapeutic attempt in the treatment of cancer pain and weight gain in patients with HIV as well as other symptoms (such as nausea and loss of appetite) if established treatments fail.Further studies involving more patients are needed to evaluate the therapeutic potential of cannabis and cannabinoids. However, special conditions in the field of palliative care make it difficult to carry out high-quality studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink